Sporadic cases of hematological malignancies in children or young adults or embryonic tumors in sibling pairs have raised speculation that genetic susceptibility factors may be associated with these diseases.
1,2 Recent genome-wide association studies in childhood acute lymphoblastic leukemia (ALL) have identified inherited gene variants associated with increased risk of disease. 3 The excess of familial cancer occurrence may also be attributable to the fact that sibs share common environmental exposures, but studies to address this aspect are scarce. 2 The acquired genetic aberrations in T-ALL include chromosomal translocations (frequently involving TCR) as well as gene rearrangements and mutations resulting in abnormal expression of genes such as NOTCH1, TAL1, HOX11, HOX11L2, LMO1 and LMO2. 4 Acquired NOTCH1 mutations are present in B50% of T-ALL cases.
5 NOTCH1 signaling is crucial for several steps in T-cell differentiation and also acts on proliferation and survival of these cells. Therefore, the mutational activation of this gene is an important factor in T-ALL pathogenesis. 4 In one case of T-ALL, NOTCH1 mutation was pre-natal and preceded SIL-TAL fusion, 6 suggesting that it might, at least in some cases, be an early and initiating genetic lesion. Animal models reveal that NOTCH1 mutations can initiate T-cell leukemia 7 or arise as secondary, genetic lesions. 8 We report a rare event of two non-twinned sisters with the same subtype of T-ALL harboring an identical NOTCH1 mutation (c.4735_4737 delGTG), who presented with onset of TCR analyses demonstrated monoclonality in both T-ALL sisters with, however, different rearrangement profiles, and direct sequencing of TCRG PCR products confirmed usage of different TCRG V regions ( Figure 1a ). These results ruled out the possibility of any technical cross-contaminations. No mutations were found in NOTCH1, PTEN and TP53 genes from the parents' blood cell analysis. PTEN and TP53 genes were also wild type in malignant cells from sisters. The search for NOTCH1 mutations was performed in the heterodimerization (HD) and PEST/TAD domains and we observed the same alteration in the HD domain from both girls (Figure 1b) . The mutation was characterized as a c.4735_4737 delGTG that results in valine deletion at 1578 position of NOTCH1 protein. This deletion was not found in the remission sample of sister 2 (or their parents) and was therefore somatic or acquired and not constitutive and inherited. Direct sequencing analyses were performed in different laboratory conditions and the same mutations were amplified on a separate occasion from additional independent leukemic DNA samples, suggesting that cross-contamination was unlikely.
To investigate the existence of other abnormalities shared or discordant between sisters, a high-density genome-wide SNP Array 6.0 assay (Affymetrix, Santa Clara, CA, USA) approach was used. Multiple copy-number abnormalities (CNAs), mostly deletions, were observed in both cases, but none was identical in the two patients, with the possible exception of 1p32/STIL (Table 1 and Supplementary Figure 1) . However, when this genomic CNAFa SIL-TAL1 fusionFwas sequenced (Figure 1c) , it differed in the sibling pair with respect to N-region insertions.
There is no other report of identical NOTCH1 mutation in non-twinned siblings in the literature. The c.4735_4737 delGTG has, however, been observed in other studies of T-ALL as an uncommon but recurrent mutation in unrelated cases. 5 Identical (monozygotic) twins with concordant T-or B-cell precursor ALL share identical, clone-specific lesions, and this is interpreted as reflecting a single-cell origin in one twin in uteroFfollowed by intraplacental spread to the second twin. 9 Such a pre-natal scenario seems very unlikely for nontwinned siblings. We therefore conclude that the identical NOTCH1 mutations in the leukemias of the sibling pair occurred most probably at different times. Concordance of T-ALL in these siblings, we speculate, arose either because of shared genetic susceptibility and/or because of common environmental exposures. The medical, social and occupational history of the siblings and their family provided no clues in this regard. The divergent clinical responses in two siblings sharing the same NOTCH1 mutations may therefore reflect the impact of the additional genetics alterations we identified.
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The authors declare no conflict of interest. Table 1 Copy number alterations in T-ALL sister cells Senescence is an inevitable consequence of life. As a result of exposure to intrinsic as well as extrinsic aging factors, cellular aging is triggered in stem cells (SCs) by gradually accumulating DNA damage due to the action of reactive oxygen species and epigenetic changes. 1 Thus, aging can be envisioned at the cellular level, as a result of altered cell function in response to changes in DNA structure that directly affects proper gene expression. In addition, SCs also aged by an intrinsic mechanism encoded by the phenomenon of telomere shortening. 2 Several well-known risk factors, such as obesity, diabetes and lack of physical activity that lead to atherosclerosis of the cardio-vascular system and impair the function of vital organs (for example, heart, kidney or brain), limit the overall lifespan. It is obvious that all these risk factors somehow must ultimately have an impact on the basic units of tissue rejuvenation, which are SCs. 1 They can directly affect SCs or damage the niches in which these cells reside and thereby impair SC self-renewal and differentiation. On the other hand, these risk factors may also lead to enhanced turnover/proliferation of SCs, resulting in premature exhaustion of these cells. The elucidation of these precise mechanisms will help to develop more efficient antiaging strategies.
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Evidence accumulates that increase in calorie uptake and insulin/insulin-like growth factor (Ins/Igf) level in peripheral blood (PB) accelerates aging. [3] [4] [5] [6] [7] [8] On the other hand, calorie restriction and decrease in Ins/Igf signaling increases lifespan in worms, flies and mammals. Furthermore, insulin-like growth factor-1 (Igf1), insulin-like growth factor-2 (Igf2) and insulin (Ins) are described as stimulators of proliferation of normal and malignant hematopoietic stem progenitor cells (HSPCs). 9 While Igf1 and Igf2 signal through tyrosine kinase receptor Igf1R, Ins together with Igf2 may activate classical insulin receptor (InsR) and all factors together may activate a hybrid Igf1R/InsR. In contrast, Igf2R serves as a 'decoy receptor' that prevents Igf2 from binding to Igf1R or InsR. While Ins is secreted after calorie uptake from pancreatic islands, Igf1 (known also as somatomedin-C) is secreted from the liver into PB in a growth hormone (GH)-dependent manner. 8 Interestingly, the expression levels of Igf2, Igf2R and Rasgrf1 (a small GTP exchange factor for Ras protein that is involved in Ins/Igf signaling) are regulated by changes in somatic imprinting. The imprinted genes have a crucial role in embryogenesis, fetal growth, the totipotential state of the zygote and the pluripotency of developmentally early SCs. 10 The expression of imprinted genes is regulated by DNA methylation within differential methylated regions (DMRs), which are CpG-rich cis-elements within their gene loci.
Recently, our group demonstrated that adult tissues including the bone marrow (BM) harbor a population of pluripotent Oct4 þ SSEA-1 þ Sca-1 þ Lin À CD45 À very small embryonic-like SCs (VSELs), 11 and postulated that these pluripotent SCs are deposited during early embryogenesis as a backup for long-term re-populating hematopoietic SCs (LT-HSCs). In fact, as recently demonstrated, BM-derived VSELs could be specified into hematopoietic lineage in co-cultures over OP-9 stroma cell support.
12 Furthermore, molecular analysis of VSELs revealed that their quiescence in adult BM and potentially premature depletion is controlled by epigenetic changes of some imprinted genes that regulate signaling of Ins/Igf (for example, Igf2-H19 locus, Igf2R and Rasgrf1).
13 Accordingly, we observed that murine BM-sorted VSELs erase the paternally methylated imprints (for example, DMRs at Igf2-H19 and Rasgrf1 loci); however, they hypermethylate the maternally methylated ones
